Suchergebnisse - "Dipeptidyl peptidase-4 inhibitor"

PubPharm (6.837)

1

Summary of Research : Efficacy and Safety of the SGLT2 Inhibitor Empagliflozin Versus Placebo and the DPP-4 Inhibitor Linagliptin Versus Placebo in Young People with Type 2 Diabetes (DINAMO): A Multicentre, Randomised, Double-Blind, Parallel Group, Phase 3 Trial

enthalten in: Diabetes therapy : research, treatment and education of diabetes and related disorders | 2024

von Laffel, L.

2

Concomitant Use of Sodium-Glucose Cotransporter 2 Inhibitors and Overactive Bladder Drugs and the Risk of Urinary Tract Infection

enthalten in: Clinical pharmacology and therapeutics | 2024

von Bea, S. | Lee, H. | Park, S. | +4

3

Effect of Luseogliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, and Dipeptidyl-Peptidase 4 Inhibitors on the Quality-of-Life and Treatment Satisfaction of Patients With Type 2 Diabetes Mellitus : A Subanalysis of a Multicenter, Open-Label, Randomized-Controlled Trial (J-SELECT Study)

enthalten in: Diabetes therapy : research, treatment and education of diabetes and related disorders | 2024

von Fukuda, M. | Sakuma, I. | Wakasa, Y. | +12

4

Preventive effects of SGLT2 inhibitors on incident hypertension in patients with diabetes who do not have hypertension

enthalten in: Hypertension research : official journal of the Japanese Society of Hypertension | 2024

von Maruhashi, T. | Higashi, Y.

CommentOn: Hypertens Res. 2024 Apr 10;:. - PMID 38600275

5

Comparison of SGLT2 inhibitors vs. DPP4 inhibitors for patients with metabolic dysfunction associated fatty liver disease and diabetes mellitus

enthalten in: Journal of endocrinological investigation | 2024

von Suzuki, Y. | Kaneko, H. | Okada, A. | +9

6

Comprehensive safety profile of dipeptidyl peptidase-4 inhibitors : a post-marketing study based on FAERS database using signal detection algorithms

enthalten in: Expert opinion on drug safety | 2024

von Yoosuf, B. | Favas Kt, M. | Dutta, P. | +1

7

Biotransformation and disposition characteristics of HSK7653, a novel long-acting dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes

enthalten in: Diabetes, obesity & metabolism | 2024

von Bian, Y. | Meng, J. | Hu, T. | +7

8

Glycaemic control and macrovascular and microvascular outcomes in type 2 diabetes : Systematic review and meta-analysis of cardiovascular outcome trials of novel glucose-lowering agents

enthalten in: Diabetes, obesity & metabolism | 2024

von Kunutsor, S. | Zaccardi, F. | Balasubramanian, V. | +5

9

Real-life experience with DPP4 inhibitors for graft dysfunction after human islet allotransplantation

enthalten in: Annales d'endocrinologie | 2024

von Lericque, V. | Chen, Y. | Defrance, F. | +2

10

Kidney and Cardiovascular Effectiveness of Empagliflozin Compared to Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes

enthalten in: The American journal of cardiology | 2024

von Edmonston, D. | Mulder, H. | Lydon, E. | +15

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[684]